4
Changes in Ownership
Serina Therapeutics, Inc. Filed Acc 0001301120-25-000030
Chief Scientific Officer sold 3,555 shares at $3.24 ($11,520)
- Chief Scientific Officer acquired 3,555 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Moreadith Randall · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +3,555 | $0.06 | $213 | 3,555 | D |
| 2025-12-11 | Sale : show line 2 in the form 10b5-1 | −3,555 | $3.24 | $11,520 | 0 | D |
| Open-market sales · 3,555 sh · avg $3.24 · $11,520 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-11 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) | −3,555 | 366,886 | D |
Loading xslF345X05/wk-form4_1765561686.xml…